Schizophrenia has been the subject of intensive neuropsychologic, neuroradiologic, neuropathologic, and neurochemical investigations. The most consistent and reproducible result from all this effort has been the demonstration of a mild degree of enlargement of the cerebral ventricles. The existence of this finding is no longer a subject of controversy, and it clearly occurs independently of psychiatric treatment and chronicity of disease. This finding represents the strongest evidence to date that a structural lesion of the central nervous system underlies schizophrenia. The localization of the lesion responsible for ventricular enlargement and for the clinical findings in schizophrenia is not as clear. Pathologic alterations in the anteriomedial temporal lobe, particularly in the hippocampus, have been independently identified by several groups, using both in vivo neuroimaging and postmortem anatomic techniques. The details and etiology of temporal lobe-hippocampal pathologic states remain to be elucidated. Neuropsychologic and cerebral blood flow studies suggest that the frontal lobe is dysfunctional in schizophrenics. However, there is little known about the neuropathologic basis and neurochemical correlates of this deficit. One of the intriguing new hypotheses about the neurologic findings in schizophrenia is that they are the result of an abnormality in the early development of the brain. The possibility that the clinical illness is a delayed manifestation of this process, perhaps because of an interaction between the early developmental deficit and later maturing functional neural systems, is a subject of speculation. While much study has been devoted to the structural and functional abnormalities underlying schizophrenia, much remains to be discovered. In the past 20 years, the development and application of new techniques, including CT, MRI, rCBF, and PET, have revolutionized the study of schizophrenia, and have produced the first consistent neuropathologic findings in this disorder. The pace of discovery has been gradually accelerating. Application of new techniques and careful use of patient selection criteria will help further decipher the neurologic basis of this disorder. There is reasonable hope that by the end of this century, the pathology and pathophysiology of this common but baffling illness will be revealed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2008-1041279 | DOI Listing |
Schizophr Res Cogn
June 2025
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.
Evidence suggests that attenuated mismatch negative (MMN) waves have a close link to auditory verbal hallucinations (AVH) and their clinical outcomes, especially impaired neural oscillations such as θ, β representing attentional control. In current study, thirty patients with schizophrenia and AVH (SZ) and twenty-nine healthy controls (HC) underwent multi-feature MMN paradigm measurements including frequency and duration deviant stimuli (fMMN and dMMN). Clinical symptoms and MMN paradigm were followed up among SZ group after 8-week treatment.
View Article and Find Full Text PDFNeuroimaging methods rely on models of neurovascular coupling that assume hemodynamic responses evolve seconds after changes in neural activity. However, emerging evidence reveals noncanonical BOLD (blood oxygen level dependent) responses that are delayed under stress and aberrant in neuropsychiatric conditions. To investigate BOLD coupling to resting-state fluctuations in neural activity, we simultaneously recorded EEG and fMRI in people with schizophrenia and psychiatrically unaffected participants.
View Article and Find Full Text PDFFront Psychiatry
January 2025
School of Mental Health, Shanxi Medical University, Taiyuan, Shanxi, China.
Background: Current research on aripiprazole adjunct therapy suggests potential benefits in improving psychiatric symptoms and metabolic disorders in patients with schizophrenia. However, the evidence remains limited due to the scarcity of research and a lack of detailed analysis on glucose and lipid metabolism indicators. This study aims to systematically review and analyze randomized controlled trials (RCTs) to evaluate the effects of aripiprazole combination therapy on both psychiatric symptoms and glycolipid metabolism.
View Article and Find Full Text PDFBJPsych Open
January 2025
Department of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
Background: Developmental regression in children, in the absence of neurological damage or trauma, presents a significant diagnostic challenge. The complexity is further compounded when it is associated with psychotic symptoms.
Method: We discuss a case series of ten children aged 6-10 years, with neurotypical development, presenting with late-onset developmental regression (>6 years of age), their clinical course and outcome at 1 year.
Eur J Obstet Gynecol Reprod Biol
January 2025
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Los Angeles General Medical Center, Los Angeles, CA, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address:
Objective: To assess clinical and obstetric characteristics associated with pregnant patients with a diagnosis of attention-deficit hyperactivity disorder (ADHD).
Methods: This serial cross-sectional study queried the Agency of Healthcare Research and Quality's Healthcare Cost and Utilization Project National Inpatient Sample. The study population was 16,759,786 hospital deliveries from 2016 to 2020.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!